Onychomycosis Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Others); Drug Type (Prescribed, OTC); Distribution Channel (Hospital and Retail Pharmacies, Online Distribution), and Geography

Report Code: TIPRE00021903 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Onychomycosis is a fungal disease or infection of the nail. It may look like white or yellow nail discoloration, separation of the nail from the nail bed, and thickening of the nail. It is more commonly seen in adults. Onychomycosis is also known as tinea unguium and accounts one-third of fungal skin infections.

MARKET DYNAMICS

The onychomycosis drug market growth is estimated to grow due to the increasing prevalence of onychomycosis, and growing awareness about the toenail infections. The growing product offering and generic production of the pharmaceutical across the world are likely to serve vital growth opportunities during the forecast period.

MARKET SCOPE

The "Onychomycosis Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Onychomycosis drug market with detailed market segmentation by, type, drug type, and distribution channel. The Onychomycosis drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Onychomycosis drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Onychomycosis drug market is segmented based on type, drug type, and distribution channel. Based on type, the market is classified as distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, candida onychomycosis, and others. Based on drug type, the market is classified as prescribed, and OTC. And based on distribution channel, the market is segmented as hospital and retail pharmacies, and online distribution.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Onychomycosis drug market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SCAM). The Onychomycosis drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Onychomycosis drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Onychomycosis drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Onychomycosis drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Onychomycosis drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for Onychomycosis drug market in the global market. Below mentioned is the list of few companies engaged in the Onychomycosis drug market.

The report also includes the profiles of key players in Onychomycosis drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Novartis AG
  •   Galderma Laboratories
  •   Bausch Health Sciences
  •   Moberg Pharma AB
  •   Medimetriks Pharmaceuticals, Inc.
  •   Merz Pharma
  •   Kaken Pharmaceutical Co., Ltd
  •   Taro Pharmaceuticals Industries Ltd
  •   GlaxoSmithKline plc
  •   Johnson and Johnson Services, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Onychomycosis Drug Market - By Type
1.3.2 Onychomycosis Drug Market - By Drug Type
1.3.3 Onychomycosis Drug Market - By Distribution Channel
1.3.4 Onychomycosis Drug Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ONYCHOMYCOSIS DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ONYCHOMYCOSIS DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ONYCHOMYCOSIS DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. ONYCHOMYCOSIS DRUG - GLOBAL MARKET OVERVIEW
6.2. ONYCHOMYCOSIS DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ONYCHOMYCOSIS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DISTAL SUBUNGUAL ONYCHOMYCOSIS
7.3.1. Overview
7.3.2. Distal Subungual Onychomycosis Market Forecast and Analysis
7.4. WHITE SUPERFICIAL ONYCHOMYCOSIS
7.4.1. Overview
7.4.2. White Superficial Onychomycosis Market Forecast and Analysis
7.5. PROXIMAL SUBUNGUAL ONYCHOMYCOSIS
7.5.1. Overview
7.5.2. Proximal Subungual Onychomycosis Market Forecast and Analysis
7.6. CANDIDA ONYCHOMYCOSIS
7.6.1. Overview
7.6.2. Candida Onychomycosis Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. ONYCHOMYCOSIS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. PRESCRIBED
8.3.1. Overview
8.3.2. Prescribed Market Forecast and Analysis
8.4. OTC
8.4.1. Overview
8.4.2. OTC Market Forecast and Analysis
9. ONYCHOMYCOSIS DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL AND RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE DISTRIBUTION
9.4.1. Overview
9.4.2. Online Distribution Market Forecast and Analysis
10. ONYCHOMYCOSIS DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Onychomycosis Drug Market Overview
10.1.2 North America Onychomycosis Drug Market Forecasts and Analysis
10.1.3 North America Onychomycosis Drug Market Forecasts and Analysis - By Type
10.1.4 North America Onychomycosis Drug Market Forecasts and Analysis - By Drug Type
10.1.5 North America Onychomycosis Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Onychomycosis Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Onychomycosis Drug Market
10.1.6.1.1 United States Onychomycosis Drug Market by Type
10.1.6.1.2 United States Onychomycosis Drug Market by Drug Type
10.1.6.1.3 United States Onychomycosis Drug Market by Distribution Channel
10.1.6.2 Canada Onychomycosis Drug Market
10.1.6.2.1 Canada Onychomycosis Drug Market by Type
10.1.6.2.2 Canada Onychomycosis Drug Market by Drug Type
10.1.6.2.3 Canada Onychomycosis Drug Market by Distribution Channel
10.1.6.3 Mexico Onychomycosis Drug Market
10.1.6.3.1 Mexico Onychomycosis Drug Market by Type
10.1.6.3.2 Mexico Onychomycosis Drug Market by Drug Type
10.1.6.3.3 Mexico Onychomycosis Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Onychomycosis Drug Market Overview
10.2.2 Europe Onychomycosis Drug Market Forecasts and Analysis
10.2.3 Europe Onychomycosis Drug Market Forecasts and Analysis - By Type
10.2.4 Europe Onychomycosis Drug Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Onychomycosis Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Onychomycosis Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Onychomycosis Drug Market
10.2.6.1.1 Germany Onychomycosis Drug Market by Type
10.2.6.1.2 Germany Onychomycosis Drug Market by Drug Type
10.2.6.1.3 Germany Onychomycosis Drug Market by Distribution Channel
10.2.6.2 France Onychomycosis Drug Market
10.2.6.2.1 France Onychomycosis Drug Market by Type
10.2.6.2.2 France Onychomycosis Drug Market by Drug Type
10.2.6.2.3 France Onychomycosis Drug Market by Distribution Channel
10.2.6.3 Italy Onychomycosis Drug Market
10.2.6.3.1 Italy Onychomycosis Drug Market by Type
10.2.6.3.2 Italy Onychomycosis Drug Market by Drug Type
10.2.6.3.3 Italy Onychomycosis Drug Market by Distribution Channel
10.2.6.4 Spain Onychomycosis Drug Market
10.2.6.4.1 Spain Onychomycosis Drug Market by Type
10.2.6.4.2 Spain Onychomycosis Drug Market by Drug Type
10.2.6.4.3 Spain Onychomycosis Drug Market by Distribution Channel
10.2.6.5 United Kingdom Onychomycosis Drug Market
10.2.6.5.1 United Kingdom Onychomycosis Drug Market by Type
10.2.6.5.2 United Kingdom Onychomycosis Drug Market by Drug Type
10.2.6.5.3 United Kingdom Onychomycosis Drug Market by Distribution Channel
10.2.6.6 Rest of Europe Onychomycosis Drug Market
10.2.6.6.1 Rest of Europe Onychomycosis Drug Market by Type
10.2.6.6.2 Rest of Europe Onychomycosis Drug Market by Drug Type
10.2.6.6.3 Rest of Europe Onychomycosis Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Onychomycosis Drug Market Overview
10.3.2 Asia-Pacific Onychomycosis Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Onychomycosis Drug Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Onychomycosis Drug Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Onychomycosis Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Onychomycosis Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Onychomycosis Drug Market
10.3.6.1.1 Australia Onychomycosis Drug Market by Type
10.3.6.1.2 Australia Onychomycosis Drug Market by Drug Type
10.3.6.1.3 Australia Onychomycosis Drug Market by Distribution Channel
10.3.6.2 China Onychomycosis Drug Market
10.3.6.2.1 China Onychomycosis Drug Market by Type
10.3.6.2.2 China Onychomycosis Drug Market by Drug Type
10.3.6.2.3 China Onychomycosis Drug Market by Distribution Channel
10.3.6.3 India Onychomycosis Drug Market
10.3.6.3.1 India Onychomycosis Drug Market by Type
10.3.6.3.2 India Onychomycosis Drug Market by Drug Type
10.3.6.3.3 India Onychomycosis Drug Market by Distribution Channel
10.3.6.4 Japan Onychomycosis Drug Market
10.3.6.4.1 Japan Onychomycosis Drug Market by Type
10.3.6.4.2 Japan Onychomycosis Drug Market by Drug Type
10.3.6.4.3 Japan Onychomycosis Drug Market by Distribution Channel
10.3.6.5 South Korea Onychomycosis Drug Market
10.3.6.5.1 South Korea Onychomycosis Drug Market by Type
10.3.6.5.2 South Korea Onychomycosis Drug Market by Drug Type
10.3.6.5.3 South Korea Onychomycosis Drug Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Onychomycosis Drug Market
10.3.6.6.1 Rest of Asia-Pacific Onychomycosis Drug Market by Type
10.3.6.6.2 Rest of Asia-Pacific Onychomycosis Drug Market by Drug Type
10.3.6.6.3 Rest of Asia-Pacific Onychomycosis Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Onychomycosis Drug Market Overview
10.4.2 Middle East and Africa Onychomycosis Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Onychomycosis Drug Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Onychomycosis Drug Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Onychomycosis Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Onychomycosis Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Onychomycosis Drug Market
10.4.6.1.1 South Africa Onychomycosis Drug Market by Type
10.4.6.1.2 South Africa Onychomycosis Drug Market by Drug Type
10.4.6.1.3 South Africa Onychomycosis Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia Onychomycosis Drug Market
10.4.6.2.1 Saudi Arabia Onychomycosis Drug Market by Type
10.4.6.2.2 Saudi Arabia Onychomycosis Drug Market by Drug Type
10.4.6.2.3 Saudi Arabia Onychomycosis Drug Market by Distribution Channel
10.4.6.3 U.A.E Onychomycosis Drug Market
10.4.6.3.1 U.A.E Onychomycosis Drug Market by Type
10.4.6.3.2 U.A.E Onychomycosis Drug Market by Drug Type
10.4.6.3.3 U.A.E Onychomycosis Drug Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Onychomycosis Drug Market
10.4.6.4.1 Rest of Middle East and Africa Onychomycosis Drug Market by Type
10.4.6.4.2 Rest of Middle East and Africa Onychomycosis Drug Market by Drug Type
10.4.6.4.3 Rest of Middle East and Africa Onychomycosis Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Onychomycosis Drug Market Overview
10.5.2 South and Central America Onychomycosis Drug Market Forecasts and Analysis
10.5.3 South and Central America Onychomycosis Drug Market Forecasts and Analysis - By Type
10.5.4 South and Central America Onychomycosis Drug Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Onychomycosis Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Onychomycosis Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Onychomycosis Drug Market
10.5.6.1.1 Brazil Onychomycosis Drug Market by Type
10.5.6.1.2 Brazil Onychomycosis Drug Market by Drug Type
10.5.6.1.3 Brazil Onychomycosis Drug Market by Distribution Channel
10.5.6.2 Argentina Onychomycosis Drug Market
10.5.6.2.1 Argentina Onychomycosis Drug Market by Type
10.5.6.2.2 Argentina Onychomycosis Drug Market by Drug Type
10.5.6.2.3 Argentina Onychomycosis Drug Market by Distribution Channel
10.5.6.3 Rest of South and Central America Onychomycosis Drug Market
10.5.6.3.1 Rest of South and Central America Onychomycosis Drug Market by Type
10.5.6.3.2 Rest of South and Central America Onychomycosis Drug Market by Drug Type
10.5.6.3.3 Rest of South and Central America Onychomycosis Drug Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ONYCHOMYCOSIS DRUG MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ONYCHOMYCOSIS DRUG MARKET, KEY COMPANY PROFILES
13.1. NOVARTIS AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GALDERMA LABORATORIES
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAUSCH HEALTH SCIENCES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MOBERG PHARMA AB
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MEDIMETRIKS PHARMACEUTICALS, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MERZ PHARMA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. KAKEN PHARMACEUTICAL CO., LTD
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TARO PHARMACEUTICALS INDUSTRIES LTD
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. GLAXOSMITHKLINE PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. JOHNSON AND JOHNSON SERVICES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Galderma Laboratories
3. Bausch Health Sciences
4. Moberg Pharma AB
5. Medimetriks Pharmaceuticals, Inc.
6. Merz Pharma
7. Kaken Pharmaceutical Co., Ltd
8. Taro Pharmaceuticals Industries Ltd
9. GlaxoSmithKline plc
10. Johnson and Johnson Services, Inc.
11. Dr. Reddy’s Laboratories Ltd
12. Ortho Dermatologics
13. Breckenridge Pharmaceutical, Inc.
14. Akorn, Inc.
15. Perrigo Company
TIPRE00021903
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking